Basic Parlodel Information

• INN (International Nonproprietary Name): Bromocriptine
• Brand Names Available In United States: Cycloset (USA, diabetes formulation); Parlodel is marketed worldwide and may be available in the US market through various suppliers.
• ATC Code: G02CB01 (Bromocriptine) — Prolactin inhibitors (ergot derivatives)
• Forms & Dosages: Tablets commonly 2.5 mg; 5 mg tablets exist in some markets.
• Manufacturers In United States: Not specified in the provided data (major global suppliers include Novartis/Novartis Sandoz, Ratiopharm, Teva, Zentiva).
• Registration Status In United States: US FDA approved (NDA 017962) for indications including hyperprolactinemia, acromegaly, and adjunctive use in Parkinson's disease.
• OTC / Rx Classification: Prescription Only (Rx only) in nearly all markets.

Important Instructions & Quick Warnings

• Always follow your prescriber's instructions; Parlodel (bromocriptine) is prescription-only in most countries.
• Avoid Parlodel if you have uncontrolled hypertension, severe psychosis, or a known ergot allergy.
• Stop the medicine and seek urgent care for severe dizziness, fainting, chest pain, sudden vision change, or hallucinations.
• Start at a low dose and take exactly as prescribed, and rise slowly from sitting or lying to reduce orthostatic hypotension.
• Keep Parlodel in its original packaging at room temperature away from moisture and heat.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Patients often ask whether to take Parlodel in the morning or evening.

For hyperprolactinemia, typical starting doses are 1.25–2.5 mg once daily or divided into twice-daily doses, with maintenance usually up to 7.5 mg per day and a maximum around 15 mg per day.

Many prescribers start low and titrate according to response and tolerability.

If dose-related dizziness or nausea occurs soon after dosing, moving the dose to bedtime can reduce daytime symptoms.

Conversely, if daytime fatigue or sedation is the main issue, taking the dose in the morning may work better.

Parkinson’s and acromegaly regimens may use divided doses and gradual titration per specialist guidance.

Discuss dosing timing with your clinician; they will balance efficacy, side effects, and daily routine.

Taking With Or Without Meals

• Food often reduces nausea — try taking Parlodel with a light snack if gastrointestinal upset occurs.
• If fasting makes symptoms worse, a small carbohydrate-containing snack with the dose is reasonable.
• For the US diabetes product Cycloset, start at 0.8 mg once daily and titrate to 1.6–4.8 mg over 2–4 weeks per product labeling.

Safety Priorities

Who Should Avoid It

Parlodel has clear absolute contraindications that must be respected.

Do not use parlodel if you have uncontrolled hypertension.

A history of severe psychotic disorders or current severe psychosis is an absolute contraindication.

A known hypersensitivity to bromocriptine or other ergot alkaloids is also a contraindication.

Postpartum use is contraindicated in women with pre-eclampsia or eclampsia or those at high cardiovascular risk.

Use caution and close monitoring for patients with cardiovascular disease, hepatic or renal impairment, a history of peptic ulcer disease, psychiatric illness, and in elderly patients.

Start at lower doses and titrate slowly in higher-risk populations to reduce hypotension and CNS adverse effects.

Activities To Limit

• Until you know the drug’s effects on you, avoid driving or operating heavy machinery because dizziness or sedation can occur.
• Avoid abrupt position changes; rise slowly from sitting or lying to reduce orthostatic hypotension risk.
• Use caution with tasks requiring alertness during dose escalation.

Dosage & Adjustments

General Regimen

Parlodel dosing follows the principle “start low, go slow.”

For hyperprolactinemia, initial dosing is commonly 1.25–2.5 mg once daily or twice daily, with maintenance often up to 7.5 mg per day and a maximum around 15 mg per day.

Acromegaly dosing also starts at 1.25–2.5 mg qd/bid and is gradually titrated; specialist care may escalate dosing up to 20–30 mg per day if needed.

Parkinson’s disease therapy begins with small doses and titrates; therapeutic ranges can reach 10–40 mg/day in typical practice, with higher specialist doses rarely used.

Cycloset for type 2 diabetes begins at 0.8 mg once daily and is titrated to 1.6–4.8 mg daily within 2–4 weeks according to tolerability.

Special Cases

• Elderly patients should start at lower doses with slower titration due to increased risk of hypotension and CNS effects.
• Children require specialist pediatric guidance; there are no standard pediatric dosing recommendations in most cases.
• Hepatic or renal impairment calls for caution, possibly lower starting doses, and closer monitoring.

User Testimonials

Positive Reports

Many patients report marked improvement in galactorrhea and normalization of prolactin on low-dose therapies such as Parlodel 2.5 mg tablets.

Patients who used parlodel for hyperprolactinemia often note quick symptom relief when titrated carefully.

Some Parkinson’s patients report additional motor benefit when bromocriptine is used as an adjunct at appropriate doses.

Diabetes patients treated with Cycloset report modest improvements in glycemic control when added to standard therapy.

Common Challenges

• Early side effects commonly reported include nausea, dizziness, headache, and fatigue; these are often transient with dose adjustments or bedtime dosing.
• Orthostatic hypotension is a frequent titration issue and can be managed by slow dose increases and positional precautions.
• Older adults or those taking multiple medications may experience sleepiness or hallucinations at higher doses.
• Some patients change to cabergoline due to better tolerability, availability, or dosing convenience.

When you speak to your prescriber, mention side effects, current medications, and cost or access concerns so they can consider alternatives if needed.

Buying Guide

Pharmacy Sources

Parlodel and its generics are available by prescription in pharmacies around the world.

In the United States, the bromocriptine diabetes formulation Cycloset is marketed specifically for glycemic control.

Generics and brands such as Parlodel Sandoz and Bromocriptin-ratiopharm are available in European markets and may be stocked by international suppliers.

Use licensed brick-and-mortar pharmacies or verified online pharmacies and always verify prescription requirements.

Price Comparison

• Generics from suppliers like Sandoz, Ratiopharm, Teva, and Zentiva typically cost less than originator brands.
• Compare per-tablet price and check for manufacturer rebates or pharmacy discount programs.
• Talk to a pharmacist about therapeutic alternatives such as cabergoline when side effects or adherence are problematic; cabergoline may cost more but often has improved tolerability.

In our online pharmacy, parlodel is available without a prescription, with discreet delivery to United States in 5-14 days; always consult your prescriber before changing therapy.

What’s Inside & How It Works

Ingredients Overview

The active ingredient in Parlodel is bromocriptine, an ergot derivative whose INN is Bromocriptine.

Tablets are commonly 2.5 mg of active bromocriptine per tablet, and some markets offer 5 mg strengths.

Inactive ingredients vary by manufacturer; ask your pharmacist about excipients if you have allergies or intolerances.

Mechanism Basics

• Bromocriptine is a dopamine D2 receptor agonist that suppresses prolactin secretion from the pituitary.
• It can reduce growth hormone release in some patients and provides dopaminergic support in the central nervous system for Parkinson’s symptoms.
• In its Cycloset formulation, bromocriptine has metabolic effects that can modestly improve glycemic control in type 2 diabetes.

Because of side-effect considerations and dosing convenience, cabergoline is often chosen over bromocriptine for hyperprolactinemia when available and affordable.

Main Indications

Approved Uses

Bromocriptine is approved globally for hyperprolactinemia, Parkinson’s disease as an adjunct, and acromegaly.

In the United States, Cycloset is the bromocriptine product approved specifically for type 2 diabetes management.

Starting and maintenance doses differ by indication and should follow prescriber instructions and specialist guidance when appropriate.

Off-Label Uses

Investigational or off-label areas include metabolic syndrome, MAFLD, cluster headaches, and certain psychiatric disorders; evidence is limited and off-label use should be discussed with a clinician.

Interaction Warnings

Food Interactions

Taking parlodel with food often reduces nausea and improves tolerability for many patients.

High-fat meals can alter absorption in some individuals, so if you notice changes in effect or side effects, discuss timing with your clinician.

Avoid alcohol during initiation if it worsens dizziness or sedation.

Follow specific Cycloset labeling for dosing and food timing to optimize tolerability and glycemic effect.

Drug Conflicts

• Antipsychotics that block D2 receptors can reduce bromocriptine effectiveness.
• Combining bromocriptine with other ergot alkaloids raises ergot toxicity risk.
• Antihypertensives can add to hypotensive effects; monitor blood pressure closely.
• CYP modulators and some macrolide antibiotics may alter metabolism and require monitoring.

Latest Evidence & Insights

Key Trial Outcomes

Clinical evidence consistently shows bromocriptine lowers prolactin and improves symptoms such as galactorrhea and amenorrhea in prolactin-related disorders.

For Parkinson’s disease, bromocriptine provides dopaminergic support, but many clinicians now prefer newer agents and levodopa preparations for primary management.

Cycloset trials demonstrate modest reductions in HbA1c when added to standard care in type 2 diabetes.

Practical Takeaways

• Cabergoline is increasingly preferred for hyperprolactinemia because of longer half-life and better tolerability.
• Bromocriptine remains relevant where cabergoline is unavailable, unaffordable, or when patients have a specific response to bromocriptine.
• Research into metabolic benefits and applications in liver disease is ongoing and currently investigational.

Alternative Choices

Safer Or Better-Tolerated Meds

Cabergoline (Dostinex, Cabaser) is often favored for hyperprolactinemia due to longer dosing intervals and fewer gastrointestinal and CNS adverse effects.

Quinagolide (Norprolac) is another option in countries where it is available.

For Parkinson’s, many prescribers prefer non-ergot dopamine agonists and levodopa/carbidopa combinations over ergot derivatives in routine care.

When To Switch

• Consider switching if side effects are intolerable despite dose adjustments, such as persistent nausea or severe orthostatic hypotension.
• Switch if prolactin control remains inadequate or if frequent dosing reduces adherence.
• Discuss cost, availability, and comorbid conditions with your prescriber when considering alternatives.

Regulation Snapshot

Approval & Legal Status

Bromocriptine is approved globally for hyperprolactinemia, Parkinson’s disease adjunctive use, and acromegaly.

In the United States the bromocriptine formulation Cycloset is FDA approved for type 2 diabetes, and bromocriptine products are generally covered by national regulatory approvals.

Prescription-only status applies in nearly all markets; check local regulatory registries for current brand listings and strengths.

Brand & Packaging Notes

Parlodel is commonly sold as 2.5 mg tablets in blister packs, and some markets supply 5 mg tablets.

Major suppliers include Novartis/Novartis Sandoz, Ratiopharm, Teva, and Zentiva, with additional regional manufacturers in some countries.

When importing or buying online, verify product registration, authenticity, and batch numbers, and purchase only from licensed pharmacies.

FAQ Section

Common Patient Questions

• Q: Can I breastfeed on Parlodel? A: Parlodel suppresses lactation and is used to stop lactation; postpartum use is contraindicated in women with pre-eclampsia/eclampsia or significant cardiovascular risk—discuss with your clinician.
• Q: What if I miss a dose? A: Take the dose as soon as remembered unless it is close to the next scheduled dose; do not double up.
• Q: How long until prolactin levels normalize? A: Many patients see biochemical improvement within weeks, but timing varies by individual and underlying cause.
• Q: Is Parlodel safe long term? A: Long-term therapy is common for persistent causes of hyperprolactinemia, with regular monitoring of prolactin and clinical follow-up.

Quick Answers & When To Call

Call your clinician or emergency services for severe dizziness, fainting, chest pain, sudden vision changes, severe psychiatric symptoms, or signs of overdose such as persistent vomiting, confusion, or arrhythmia.

Tapering or stopping long-term therapy should be guided by a specialist and follow monitoring of prolactin and clinical symptoms.

Keep a printable one-page checklist with emergency contacts, current dose, and dates of last labs to share with your clinician if problems arise.

Guidelines For Proper Use

Practical Daily Checklist

• Take Parlodel exactly as prescribed and do not change dose without consulting your prescriber.
• Store at room temperature away from moisture and light, keeping the tablets in their original packaging.
• Rise slowly from bed or after sitting to reduce orthostatic hypotension.
• Have a small snack available if dose-related nausea occurs and carry emergency contact information for severe reactions.

Monitoring & Follow-Up

Monitor prolactin levels periodically for hyperprolactinemia and arrange clinical reviews to assess side effects and efficacy.

Check blood pressure during titration and perform ECG or specialist surveillance when higher cumulative doses or QT-prolonging drug combinations are present.

Long-term therapy should include periodic pituitary imaging and endocrine input to evaluate tumor size and the need for dose tapering.

If switching agents, follow specialist advice regarding overlap or washout to avoid rebound symptoms or adverse interactions.

Delivery Across United States